AstraZeneca will start discussing emergency approval of its experimental COVID-19 vaccine with U.S. regulators once it has good trial data from Britain, South...
AstraZeneca will start discussing emergency approval of its experimental COVID-19 vaccine with U.S. regulators once it has good trial data from Britain, South...
AstraZeneca, the British drugmaker working on one of the world's leading COVID-19 vaccine candidates, beat third-quarter sales estimates on Thursday and reiterated it...
Newly introduced restrictions could slow economic recovery or even lead to a contraction in Spain and other European countries in the fourth quarter,...
LONDON: The COVID-19 vaccine developed by the University of Oxford could present late-stage trial results before the year end but it is unclear...
Britain, which has the highest official death toll in Europe from COVID-19, is grappling with more than 20,000 new coronavirus cases a day...
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in...
Global coronavirus cases rose by more than 500,000 for the first time on Wednesday, a record one-day increase as countries across the Northern...
Britain resisted pressure on Thursday to impose a second nationwide lockdown after France and Germany ordered sweeping restrictions on social life to contain...
London - Researchers have reported that some patients recovered from Covid-19 could still carry the virus, suggesting that recovered patients should be more...
The Ear, Nose and Throat (ENT) Surgery Department at Al-Ahli Hospital is staffed with western-trained and highly qualified physicians. They provide the most...
The Ear, Nose and Throat (ENT) Surgery Department at Al-Ahli Hospital recently performed surgery on a patient having a rare condition affecting some...
French drugmaker Sanofi SA and Britain's GlaxoSmithKline plan to make 200 million doses of their COVID-19 vaccine candidate available to the vaccine allocation...
European governments prepared on Tuesday to introduce new restrictions to curb a surge in infections, and are looking to buy millions of COVID-19...
Drugmaker Pfizer Inc said on Tuesday it was not yet ready to release data from the late-stage trial of the COVID-19 vaccine candidate...
London: People recovering from COVID-19 may suffer significant brain impact, with the worst cases of the linked to mental decline equivalent to the...
Pfizer Inc and Johnson & Johnson are seeking input from a U.S. Food and Drug Administration advisory committee on retaining and attracting volunteers...
LONDON: AstraZeneca's Oxford COVID-19 vaccine accurately follows the genetic instructions programmed into it by its developers to successfully provoke a strong immune response,...
The U.S. Food and Drug Administration approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first...
